Back
Day Range
$76.18
$81.46
52-Week Range
$26.20
$84.56
Volume
3,451,894
50D / 200D Avg
$71.39
/
$55.53
Prev Close
$66.04
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -17.2 | 0.4 |
| P/B | 4.9 | 2.9 |
| ROE % | -31.6 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$105.63
+33.3%
Low: $83.00
High: $137.00
Forward EPS
-$4.68
Est. Revenue
0
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$0.96
-$0.96 – -$0.96
|
800 M | 4 |
| FY2029 |
-$5.90
-$5.90 – -$5.90
|
200 M | 4 |
| FY2028 |
-$6.59
-$11.69 – -$4.90
|
14 M | 10 |
Key Takeaways
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -232.60M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-31.57%
ROIC-23.47%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.01
Current Ratio26.57
Interest Coverage0.00
Valuation
P/E Ratio
-17.15
P/B Ratio4.85
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -255.84M |
| ROE | -31.57% | ROA | -27.30% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -232.60M |
| ROIC | -23.47% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 26.57 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -17.15 | P/B Ratio | 4.85 |
| P/S Ratio | N/A | PEG Ratio | -0.64 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 4.39B | Enterprise Value | 4.26B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -255.84M | -182.15M | -83.99M | -39.79M |
| EPS (Diluted) | -4.22 | -3.30 | -1.66 | -0.79 |
| Gross Profit | -1.42M | 0.0 | 0.0 | 0.0 |
| Operating Income | -285.60M | -216.87M | -93.00M | -30.73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 937.13M | 753.95M | 401.40M | 152.06M |
| Total Liabilities | 33.25M | 37.16M | 21.49M | 9.98M |
| Shareholders' Equity | 903.88M | 716.79M | 379.91M | 142.08M |
| Total Debt | 8.85M | 11.83M | 2.03M | 0.0 |
| Cash & Equivalents | 131.55M | 141.79M | 118.32M | 151.89M |
| Current Assets | 741.36M | 529.71M | 398.41M | 152.06M |
| Current Liabilities | 27.91M | 28.56M | 20.56M | 9.98M |